Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the superiority of the new low sodium peritoneal dialysis
(PD) solution PDsol 12 in comparison with a conventional, already marketed solution,
Gambrosol trio 40, in the treatment of the hypertensive peritoneal dialysis patients with aim
to decrease hypertension and to improve the sodium/water balance.